title: Cancer prognostic approved.
authors.forename: V
authors.initials: V
authors.lastname: Brower
authors.forename: K
authors.initials: K
authors.lastname: Chahine
authors.forename: E
authors.initials: E
authors.lastname: Dorey
authors.forename: A
authors.initials: A
authors.lastname: Dove
authors.forename: M
authors.initials: M
authors.lastname: Francisco
authors.forename: J
authors.initials: J
authors.lastname: Hodgson
authors.forename: A
authors.initials: A
authors.lastname: Michael
authors.forename: A
authors.initials: A
authors.lastname: Marshall
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis*; D018572:Disease-Free Survival; D017277:Drug Approval; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases